COMMUNIQUÉS West-GlobeNewswire

You have the green light to save a life: April 22-28 is National Organ and Tissue Donation Awareness Week
23/04/2018
This week we remind Canadians to talk with their friends, family and loved ones to ensure their organ donation wishes and decisions are understood. OTTAWA, April 23, 2018 (GLOBE NEWSWIRE) -- Green is the official colour [...]
Abba Medix Receives its License to Produce Cannabis Oil
23/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to [...]
Wildflower Completes Acquisition of Retail and Cultivation Licenses in LA
23/04/2018
VANCOUVER, British Columbia, April 23, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“ Wildflower ” or the " Company ") has completed the acquisition of multiple California marijuana licenses [...]
AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)
23/04/2018
BROOKLYN, N.Y., April 23, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), today provided an update on the first nine treated patients in its ongoing Phase IIa trial of MS1819- [...]
Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Developments on May 3, 2018
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia
23/04/2018
NOVATO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
Vystar Acquires Assets of NHS Holdings
23/04/2018
Purchases Assets of NHS at a 70% Discount From $4.6 Million Valuation Transitions Vystar Focus from Rubber Commodities to Higher Revenue, Higher Margin Product Sales WORCESTER, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- [...]
Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Acology Purchases Entire MedTainer Intellectual Property Portfolio
23/04/2018
Purchase Provides Catalysts to Rapid Global Expansion CORONA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for [...]
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares
23/04/2018
MINNEAPOLIS, April 23, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Alder BioPharmaceuticals® Appoints Eric Carter, Ph.D., M.D., as Interim Chief Medical Officer
23/04/2018
BOTHELL, Wash., April 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc., (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
23/04/2018
WESTMINSTER, Colo., April 23, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
HempAmericana Announces Augusta CBD Oil Facility Now “Open for Business”
23/04/2018
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that the new Vitalis R-200 high-capacity supercritical CO2 CBD Oil [...]
Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, [...]
Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function
23/04/2018
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
23/04/2018
EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA
23/04/2018
First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation NEW YORK and CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical- [...]
Achaogen Highlights Plazomicin Presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
23/04/2018
-- Study findings support the potential for plazomicin to address difficult-to-treat infections, including those caused by carbapenem-resistant Enterobacteriaceae -- SOUTH SAN FRANCISCO, Calif., April 23, 2018 (GLOBE [...]
Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin
23/04/2018
BEVERLY, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a drug supply contract [...]

Pages